Fierce Pharma

JUNE 5, 2024

The scope of Bristol Myers Squibb’s $1.5 billion savings drive is beginning to come into focus. | Starting this month, BMS will begin the process of laying off around 863 employees in Lawrenceville, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) alert from the state. The move forms part of BMS’ campaign to shave off $1.5 billion in costs by the end of 2025, a company spokesperson said over email.

321

321

MedCity News

JUNE 5, 2024

Dollar General and DocGo have mutually decided to end their mobile clinic pilot. The decision comes as numerous retailers have struggled in the healthcare sector. The post Another Retailer Bites the Dust. Is There Still Hope for Retailers After Dollar General/DocGo End Pilot? appeared first on MedCity News.

Retail 122

Retail Healthcare Healthcare 122

Fierce Pharma

JUNE 5, 2024

After 23 years at Eli Lilly, including the last three as its CFO, Anat Ashkenazi is leaving to take the same role at Google's parent company Alphabet.

311

311

MedCity News

JUNE 5, 2024

As the volume of healthcare data accelerates, health system leaders must take critical steps to elevate the quality, completeness and accessibility of data they capture, manage and aggregate. The post Healthcare’s Data Problem: So Much Data, yet So Little Data Fidelity appeared first on MedCity News.

Healthcare 119

Healthcare Healthcare Management 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JUNE 5, 2024

Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease. | Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease.

Patients 288

Patients 288

MedCity News

JUNE 5, 2024

Novo Nordisk’s focus on diabetes and obesity shape its business development work, but the company is also exploring other areas. Top Novo Nordisk M&A executive John McDonald discussed his company’s strategy during a session at the BIO conference in San Diego. The post At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s appeared first on MedCity News.

Biopharma 119

Biopharma Pharma 119

PharmaVoice

JUNE 5, 2024

Bucking conventional fundraising, FibroBiologics’ CEO Pete O’Heeron explains why the biotech company bet on themselves in the public market.

Marketing 119

Marketing 119

MedCity News

JUNE 5, 2024

We’re in for a bumpy ride near term, but value-based specialty care (VBSC) is coming and – if done right – has the potential to transform how we care for millions of patients. The post Making the Transition to Value-Based Specialty Care appeared first on MedCity News.

Patients 117

Patients 117

pharmaphorum

JUNE 5, 2024

An initiative set up by the FDA to accelerate the development of therapies for rare disease in the same way that Operation Warp Speed delivered COVID-19 vaccine has chosen its first pilot programme candidates.

FDA 116

FDA 116

MedCity News

JUNE 5, 2024

More than 100 skilled consultants to self-insured employers shared their perspectives on the changing dynamics in healthcare benefits in MedCity News’ second annual 2024 Benefit Consultant Sentiment Index (The Index): Benefit Consultants’ Perspective on Shifting Employer Healthcare Landscape. The report functions as an insider’s guide to understanding how healthcare trends are shaping employer benefit decisions from the perspective of consultants.

Consulting 111

Consulting Insurance Healthcare Healthcare 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

JUNE 5, 2024

KRAS inhibitors from Eli Lilly, Genfleet, and InxMed make their case for use in NSCLC at ASCO, as they case down Amgen and Bristol-Myers Squibb's market drugs

Marketing 116

Marketing 116

PharmaTech

JUNE 5, 2024

Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.

110

110

pharmaphorum

JUNE 5, 2024

PHTI's latest report finds that digital therapies for musculoskeletal conditions like low back pain can deliver clinically meaningful benefits

113

113

Pharmaceutical Commerce

JUNE 5, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Patients 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JUNE 5, 2024

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term efficacy and safety.

Safety 111

Safety FDA 111

Pharmaceutical Commerce

JUNE 5, 2024

The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.

Manufacturing 100

Manufacturing 100

pharmaphorum

JUNE 5, 2024

NHS hospitals in London have declared a critical incident caused by a ransomware attack on a pathology services provider, leading to cancelled procedures and patients having to be transferred to different care providers. The attack on Synnovis has had an impact on patient care at Guy’s and St Thomas’ and King’s College Hospital NHS Foundation Trusts, as well as GP services in southeast London, according to an NHS England statement.

Patients 105

Patients Leads 105

PharmaTimes

JUNE 5, 2024

Extended phase 2 study highlights macrophage cell therapy’s efficacy

100

100

Advertisement

Pharmaceutical Technology

JUNE 5, 2024

The US FDA has granted orphan drug designation to Be Biopharma’s (Be Bio) BE-101 for the treatment of haemophilia B.

FDA 98

FDA 98

Copyright Clearance Center

JUNE 5, 2024

June 5, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announced its collaboration with key industry stakeholders to launch the Leiden Institute for FAIR and Equitable Science (LIFES). In recognition of the challenges that exist with data reuse within the global research community, LIFES is a joint effort by an international public-private partnership of eleven academic and private organizations to build a wide and diverse network

Ethics 98

Ethics Education Networking Leads 98

European Pharmaceutical Review

JUNE 5, 2024

New clinical data from a Phase II trial for rectal cancer has revealed a 100 percent clinical complete response rate following first-line therapy with Jemperli (dostarlimab-gxly). These findings from GSK reflect outcomes from 42 patients with mismatch repair deficient (dMMR) locally advanced rectal cancer who finished the treatment. The trial investigated the therapy as an alternative to surgery.

Safety 98

Safety Patients Manufacturing Medicine 98

PharmaTimes

JUNE 5, 2024

Phase 3 research suggests a significant leap forward in myeloma management

Management 95

Management 95

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

European Pharmaceutical Review

JUNE 5, 2024

A report by the Business Research Company predicts that the small molecule injectable drugs market will value $355.14 billion in 2028. As such, the compound annual growth rate (CAGR) is expected to be 12.8 percent up to this period. Factors that are anticipated to facilitate this growth of the market include personalised treatments , supply chain optimisation and use of real-world evidence, according to the research.

Marketing 97

Marketing Pharmaceutical Patients 97

MedCity News

JUNE 5, 2024

CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.

Medical 94

Medical Management Leads 94

Pharmaceutical Commerce

JUNE 5, 2024

The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.

81

81

Pharmaceutical Technology

JUNE 5, 2024

5 June marks World Environment Day, an annual celebration that encourages global awareness and action to protect the environment.

72

72

Advertisement

Distribution

Pharmacy Times

JUNE 5, 2024

The investigators are optimistic that the data can establish stress-related pathways while revealing potential therapeutic options for patients with major depressive disorder and post-traumatic stress disorder.

Patients 59

Patients 59

Rep-Lite

JUNE 5, 2024

In the highly competitive medical sales industry, finding top-tier talent is a constant challenge. The power of networking can be used to foster strong connections, and it is at this point medical sales recruiters gain a significant edge in attracting and securing the best candidates. At Rep-Lite, we understand the importance of building a robust network.

Medical sales 52

Medical sales Recruitment Networking Sales 52

Pharmacy Times

JUNE 5, 2024

For patients with a blood eosinophil count of 150 cells/µL or greater, tezepelumab had a significant reduction of approximately 37% in the rate of moderate or severe exacerbations.

Patients 52

Patients 52

Pharmaceutical Technology

JUNE 5, 2024

Having a competent and efficient partner by your side can elevate your mass production to new levels of efficiency and sustainable success.

Pharma 52

Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales